Is Hybridoma Production About To Take A Quantum Leap Forward?

Recently published research* has established the ability of Neowater® to enhance the various processes involved in the production of pure human monoclonal antibodies by refining the standard hybridoma production process.Biopharmaceutical companies have started to evaluate the use of fully human monoclonal antibodies as a complementary or primary therapeutic agent against a variety of diseases.

More: continued here

Filed under: Biology on February 18th, 2008